Hypercholesterolemia
HeFH · CVRM · 3 drugs · 3 indications
Elevated LDL cholesterol. Includes familial hypercholesterolemia.
Competitive Landscape (3 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Enlicitide | MRK | Oral PCSK9 inhibitor | Peptide | PO | PHASE3 |
| Leqvio | ALNY, NVS | PCSK9 silencing | siRNA | SC | APPROVED |
| Praluent | REGN | PCSK9 inhibitor (monoclonal antibody) | Monoclonal antibody | SC | APPROVED |
Indications (3)
Hypercholesterolemia / ASCVD (LDL-C lowering)
Primary hypercholesterolemia
Upcoming Catalysts
Leqvio - Commercial Uptake UpdatesCOMMERCIAL
NVS2026
Data from Supabase · Updated 2026-03-24